MicroTech Medical (Hangzhou) Co., Ltd. engages in the research and development, manufacture, and commercialization of diabetes management medical devices and consumables. The company is headquartered in Hangzhou, Zhejiang and currently employs 645 full-time employees. The company went IPO on 2021-10-19. The firm's main business is engaged in the manufacture and sale of blood glucose monitoring system (BGMS), continuous glucose monitoring system (CGMS) and insulin pump systems. The firm has the portfolio of products in the field of diabetes monitoring, treatment and management, covering patch insulin pump system, CGMS, closed-loop artificial pancreas system, BGMS products, as well as diabetes digital management software. The firm conducts its businesses in the domestic and overseas markets.
02235.HK stock price ended at $7.75 on 星期二, after dropping 0.39%
On the latest trading day Jan 20, 2026, the stock price of 02235.HK fell by 0.39%, dropping from $7.78 to $7.75. During the session, the stock saw a volatility of 0.39%, with prices oscillating between a daily low of $7.75 and a high of $7.78. On the latest trading day, the trading volume for 02235.HK decreased by 61.4K shares, aligning with the declining prices, which may indicate weakening market confidence in the near term. In total, 1.3K shares were traded, with a market value of approximately $1.2B.